From May 11 to 14, 2025, WCC Biomedical had the privilege of participating as a speaker and exhibitor at the Microneedles Conference 2025, held in Brisbane, Australia. Widely regarded as the premier international event for microneedles innovation, this year’s conference brought together hundreds of technical leaders, researchers, pharmaceutical companies, and global health organizations from around the world to explore the latest developments in microneedle technology.

At this year’s forum, WCC introduced our company to an international audience and showcased our scalable precision loading and coating breakthrough through three engaging presentations focused on:

• WCC's mRNA-LNP MAPs

• WCC's Pain-relief MAPs - DS MAPs

• MINIMAP™ Impact to Scaling up Microarray Patches Production

Our presentations at the conference attracted strong interest from stakeholders across sectors, including pharmaceutical companies, academic institutions, government agencies, and non-profit organizations. Many visited our exhibition booth and expressed interest in future collaboration—especially around our proprietary MINIMAP™ platform, which emerged as a game-changing advancement in the microneedle space.

MINIMAP™ sparked particularly enthusiastic discussions. Designed for speed, flexibility, and accessibility, it enables rapid screening, supports small-scale patch production, and—most importantly—is fully portable. This makes it ideal for deployment at the point of care, especially in remote or underserved areas, dramatically expanding the reach of microarray patches technology. 

If you’re interested in learning more about our technology or exploring collaboration opportunities, we would be delighted to speak with you—visit us at Booth M432!